Estradiol

(Redirected from Estrofem)
Jump to: navigation, search

Synonyms: D-Estradiol, D-Oestradiol, Estradiol-17beta, Estradiol Valerate, Estradiol Cypionate, Dihydroxyestrin, Dihydroxyoestrin, Dihydroxyesterin, Dihydrofollicular Hormone, Dihydrofolliculin, Cis-Estradiol, Cis-Oestradiol, Beta-Estradiol, estradiol, 17-beta.

Brand Names: Aerodiol, Agofollin, Alora, Altrad, Amnestrogen, Aquadiol, Bardiol, Climaderm, Climara, Combipatch, Compudose, Compudose 200, Compudose 365, Corpagen, Delestrogen, Depo-Estradiol, Dermestril, Dihydromenformon, Dihydrotheelin, Dimenformon, Dimenformon Prolongatum, Diogyn, Diogynets, Divigel, Encore, Esclim, Estinyl, Estrace, Estraderm, Estraderm Tts, Estradurin, Estrasorb, Estreva, Estrifam, Estring, Estring Vaginal Ring, Estroclim, Estroclim 50, Estrofem 2, Estrofem Forte, Estrogel, Estrogens, Esterified, Estrovite, Evorel, Extrasorb, Femestral, Femestrol, Feminone, Femogen, Fempatch, Femring, Femtrace, Femtran, Follicyclin, Ginedisc, Ginosedol, Gynergon, Gynestrel, Gynodiol, Gynoestryl, Gynpolar, Innofem, Lamdiol, Lynoral, Macrodiol, Macrol, Menest, Menorest, Menostar, Microdiol, Nordicol, Oestergon, Oestradiol, Oestradiol R, Oestrogel, Oestroglandol, Oestrogynal, Ovahormon, Ovasterol, Ovastevol, Ovociclina, Ovocyclin, Ovocycline, Ovocylin, Perlatanol, Primofol, Profoliol, Profoliol B, Progynon, Progynon Dh, Progynon-Dh, Ricifon, Ritsifon, Sandrena Gel, Sisare Gel, Sk-Estrogens, Soldep, Sotipox, Syndiol, Systen, Tradelia, Trial Sat, Trocosone, Vagifem, Vivelle, Zerella, Zumenon, Elestrin, Evamist.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

When estrogen is prescribed for a postmenopausal woman with a uterus, a progestin should also be initiated to reduce the risk of endometrial cancer. A woman without a uterus does not need progestin. Use of estrogen, alone or in combination with a progestin, should be with the lowest effective dose and for the shortest duration consistent with treatment goals and risks for the individual woman. Patients should be reevaluated periodically as clinically appropriate (e.g., 3-month to 6-month intervals) to determine if treatment is still necessary. For women who have a uterus, adequate diagnostic measures, such as endometrial sampling, when indicated, should be undertaken to rule out malignancy in cases of undiagnosed persistent or recurring abnormal vaginal bleeding.
Patients should be started at the lowest dose for the indication.
1. For treatment of moderate to severe vasomotor symptoms, vulval and vaginal atrophy associated with the menopause, the lowest dose and regimen that will control symptoms should be chosen and medication should be discontinued as promptly as possible.
Attempts to discontinue or taper medication should be made at 3-month to 6-month intervals. The usual initial dosage range is 1 to 2 mg daily of Estradiol adjusted as necessary to control presenting symptoms. The minimal effective dose for maintenance therapy should be determined by titration. Administration should be cyclic (e.g., 3 weeks on and 1 week off).
2. For treatment of female hypoestrogenism due to hypogonadism, castration, or primary ovarian failure.
Treatment is usually initiated with a dose of 1 to 2 mg daily of Estradiol, adjusted as necessary to control presenting symptoms; the minimal effective dose for maintenance therapy should be determined by titration.
3. For treatment of breast cancer, for palliation only, in appropriately selected women and men with metastatic disease.
Suggested dosage is 10 mg three times daily for a period of at least three months.
4. For treatment of advanced androgen-dependent carcinoma of the prostate, for palliation only.
Suggested dosage is 1 to 2 mg three times daily. The effectiveness of therapy can be judged by phosphatase determinations as well as by symptomatic improvement of the patient.
5. For prevention of osteoporosis.
When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should be considered only for women at significant risk of osteoporosis and for whom non-estrogen medications are not considered to be appropriate.
The lowest effective dose of Estradiol has not been determined.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Estradiol

Return to top

Publication Resources

Most Recent Articles on Estradiol

Review Articles on Estradiol

Articles on Estradiol in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Estradiol

Return to top

Trial Resources

Ongoing Trials with Estradiol at Clinical Trials.gov

Trial Results with Estradiol

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Estradiol

Cochrane Collaboration on Estradiol

Cost Effectiveness of Estradiol

Return to top

Media Resources

Powerpoint Slides on Estradiol

Images of Estradiol

Podcasts & MP3s on Estradiol

Videos on Estradiol

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Estradiol

Discussion Groups on Estradiol

Patient Handouts on Estradiol

Blogs on Estradiol

Estradiol in the News

Estradiol in the Marketplace

Return to top

International Resources

Estradiol en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox